Predicting survival in ambulatory patients with severe heart failure on beta-blocker therapy.

[1]  G. Ewald,et al.  The effect of β-adrenergic blockers on the prognostic value of peak exercise oxygen uptake in patients with heart failure , 2003 .

[2]  G. MacGowan,et al.  Impact of beta-blocker therapy on functional capacity criteria for heart transplant listing. , 2003, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[3]  W. Kübler,et al.  Impact of beta-blocker treatment on the prognostic value of currently used risk predictors in congestive heart failure. , 2002, Journal of the American College of Cardiology.

[4]  R. Berger,et al.  Long-term effect of atenolol on ejection fraction, symptoms, and exercise variables in patients with advanced left ventricular dysfunction. , 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[5]  W. Kübler,et al.  Risk stratification in middle‐aged patients with congestive heart failure: prospective comparison of the Heart Failure Survival Score (HFSS) and a simplified two‐variable model , 2001, European journal of heart failure.

[6]  H. Scheld,et al.  Effect of receiving a heart transplant: analysis of a national cohort entered on to a waiting list, stratified by heart failure severity , 2000, BMJ : British Medical Journal.

[7]  J. Myers,et al.  Cardiopulmonary exercise testing and prognosis in severe heart failure: 14 mL/kg/min revisited. , 2000, American heart journal.

[8]  Fach,et al.  Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF) , 1999, The Lancet.

[9]  J. Schwartz,et al.  Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. , 1996, Circulation.

[10]  J. Cohn,et al.  The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. , 1996, The New England journal of medicine.

[11]  J. Medbø,et al.  The effect of acute vs chronic treatment with beta-adrenoceptor blockade on exercise performance, haemodynamic and metabolic parameters in healthy men and women. , 1996, British journal of clinical pharmacology.

[12]  D. Mancini,et al.  Is percentage of predicted maximal exercise oxygen consumption a better predictor of survival than peak exercise oxygen consumption for patients with severe heart failure? , 1995, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[13]  J R Wilson,et al.  Value of Peak Exercise Oxygen Consumption for Optimal Timing of Cardiac Transplantation in Ambulatory Patients With Heart Failure , 1991, Circulation.